Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Hemab Therapeutics Holdings, Inc. (COAG)
Market Closed
10 Aug, 20:00
NASDAQ (NGS)
All
(1)
US
(1)
NASDAQ (NGS)
Primary
$
49.
87
+0.21
+0.4229%
$
100.18M
Market Cap
-
P/E Ratio
-
Div Yield
292,181
Volume
-
Eps
$
49.66
Previous Close
Investors:
Analysts:
RL
Watching
Watch
Add Transaction
Day Range
48.76
51.8
Year Range
23
53.61
Want to track
COAG
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Statistics
News
Historical Data
Investors
Analysts
Hemab Therapeutics Holdings, Inc. Analysts
Name
Quantity
Cost
Value
Profit ($)
Gain (%)
RL
Richard Law
Goldman Sachs
4,348.13
$151,939.35
$205,492.76
$53,553.41
35.25%
1